School of Medicine
Showing 51-100 of 326 Results
-
Quynh-Thu Le, MD
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsMy laboratory focuses on identifying pathways and biomarkers of treatment resistance in head and neck cancer using clinical samples. We explore approaches to modulate these pathways through preclinical models (cell lines, organoids, tumor bearing mice) in order to develop precise strategies against these resistant mechanisms. At the same time, we are also studying pathways involved in treatment-related toxicity and develop strategies to prevent or overcome these toxicities.
-
Scheherazade Le, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsNeurophysiology, Epilepsy/EEG, Intraoperative Neurophysiologic Monitoring,Tuberous Sclerosis, Autoimmune Epilepsy/Encephalitis, Autoimmune Encephalitis, Immune-Mediated Epilepsy
-
Melanie Lean
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioMelanie Lean, Clin.Psych.D. is a Californian licensed clinical psychologist, Clinical Assistant Professor, and assistant director of research in the INSPIRE early psychosis clinic, Stanford University School of Medicine. She provides Cognitive Behavioral Therapy for psychosis (CBTp) within the recovery oriented and trauma informed framework of the INSPIRE clinic. Dr Lean received her doctorate from University College London, UK and completed her postdoctoral fellowship at Stanford University. She is a mixed methods researcher, with over 15 years’ experience in mental health research, working across a range of settings with a focus on severe and enduring mental illness and ways to improve service provision for this population. She has specialized knowledge in self-management and peer support interventions for people with psychosis and has experience working alongside service user researchers in the evaluation and delivery of study interventions. Dr Lean is also trained in psychedelic assisted therapy and works on a range of clinical trials investigating psilocybin for treatment resistant depression.
-
Hayley Wheeler Leatham, MD
Clinical Assistant Professor, Dermatology
BioDr. Leatham is a dermatologist and clinical assistant professor in the Department of Dermatology at Stanford University School of Medicine. Her clinical interests include the prevention and treatment of skin cancer, acne, psoriasis, and dermatologic surgery, as well as the full range of general dermatologic skin conditions.
Dr. Leatham’s research interests include the relationship between interferon expression, clinical characteristics, and prognosis in patients with dermatomyositis. She has co-authored articles on clinical factors associated with this condition, as well as other subjects such as blistering dermatosis as a sign of multiple myeloma relapse. Her work has appeared in the Journal of Cutaneous Pathology, Journal of the American Academy of Dermatology Case Reports, Medicine, and other journals.
Presentations by Dr. Leatham have addressed cutaneous coccidioidomycosis and a range of dermatomyositis-related topics, including interferon activity and malignancy screening outcomes. She has delivered these presentations at the annual meetings of the American Academy of Dermatology, Rheumatologic Dermatology Society, American College of Rheumatology, and Society of Investigative Dermatology.
During medical school, Dr. Leatham was honored to be selected into the Stanford Gold Humanism Honor Society for demonstrating excellence in clinical care, leadership, compassion, and dedication to service. She was also inducted into the Alpha Omega Alpha medical honor society during her chief resident year.
Her community service activities include volunteering for SUNSPORT, the Stanford University Network for Sun Protection, Outreach, Research, and Teamwork, the most comprehensive sun protection outreach and research program of any university in the nation. This initiative provides risk awareness and sun protection education to Stanford outdoor athletes and fans, as well as all students, faculty, and staff. It is a collaborative effort of the Stanford Department of Dermatology, Stanford Cancer Institute, Stanford Hospital & Clinics, and Stanford Athletics. -
Alice A. Lee
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Lee's research focuses on the early detection of pancreatic cancer, including the investigation of risk factors for pancreatic cancer and biomarkers to detect early cancer.
-
Anson Lee
Assistant Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)
BioDr. Anson Lee specializes in the surgical treatment of all heart diseases, including ischemic heart disease, structural heart disease, aortic disease, and arrhythmias. He has practiced cardiothoracic surgery at Stanford since 2015. Dr. Lee has a special interest in the surgical treatment of abnormal heart rhythms and minimally invasive techniques to treat heart disease.
-
Bomi Lee
Instructor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsImmune mechanisms in pancreatic diseases, pancreatitis and pancreatic cancer
-
Byrne Lee, MD FACS
Clinical Professor, Surgery - General Surgery
BioDr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.
Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.
Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries. -
Carolyn Lee MD PhD
Assistant Professor of Dermatology
BioA native of Queens, New York, Dr. Carolyn Lee joined the Stanford Dermatology faculty in February of 2016 as a specialist in the management of patients at a high risk for developing skin cancer. This year, she has been a featured presenter at both the Society for Investigative Dermatology Annual Meeting and the Gordon Research Conference on Epithelial Differentiation and Keratinization. Dr. Lee graduated with honors from Yale University in 1998 with a BS in Biology and received her MD and PhD from Georgetown University with a specialty in tumor biology in 2006. She completed her Dermatology residency at Stanford in 2010 and a Postdoctoral Fellowship in epithelial biology in the lab of Dr. Paul Khavari in December of 2015. Dr. Lee possesses a strong interest in understanding the mechanisms of high-risk non-melanoma skin cancer and is currently a member of Stanford’s High-Risk Non-Melanoma Skin Cancer Working Group.
-
David Lee, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests1. Novel treatments and devices for the treatment of valvular disease
2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
3. Novel approaches to coronary revascularization
4. Closure devices for atrial septal defects and patent foramen ovale
5. Novel treatments for hypertension -
Grace Eun Lee, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioGrace Lee, Ph.D. is a Clinical Assistant Professor and a CA Licensed Clinical Psychologist in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Lee specializes in evidence-based, trauma-informed, and compassion-focused care for individuals presenting with psychosis. She is currently providing Cognitive Behavioral Therapy for Psychosis (CBTp), Cognitive Processing Therapy, and Prolonged Exposure Therapy within the INSPIRE Clinic and PTSD Clinic. She also leads trainings in CBTp to providers supporting individuals with psychosis.
-
Grace Lee
Professor of Pediatrics (Infectious Diseases)
BioDr. Grace Lee is Chief Quality Officer and the Christopher G. Dawes Endowed Director of Quality at Stanford Medicine Children’s Health and Lucile Packard Children’s Hospital Stanford, and Associate Dean for Maternal and Child Health (Quality and Safety) and Professor of Pediatrics at Stanford University School of Medicine. She oversees the Center for Pediatric and Maternal Value that seeks to improve quality, safety, patient experience and health equity across the organization. Dr. Lee previously served as a member of the Institute of Medicine Committee (IOM) to Review Priorities in the National Vaccine Plan, the IOM Committee on the Ethical and Scientific Issues in Studying the Safety of Approved Drugs, the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response, and AHRQ's Healthcare Safety and Quality Improvement Research Study Section. She also served as a Board Member for the Society for Healthcare Epidemiology of America (SHEA), Pediatric Infectious Diseases Society (PIDS), and the National Academy of Medicine (NAM) Board on Population Health and Public Health Practice. She was previously the Chair of the U.S. Advisory Committee on Immunization Practices (ACIP) that recommends vaccines for the U.S. population, and she is an elected member of the National Academy of Medicine.
-
Jake J. Lee, MD
Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
BioDr. Lee is a fellowship-trained head and neck surgical oncologist with Stanford Medicine Cancer Center’s Head and Neck Cancer Program. He is also a clinical assistant professor in the Department of Otolaryngology—Head & Neck Surgery at Stanford University School of Medicine.
He treats benign and malignant tumors of the head and neck, including oral cancer, tonsil cancer, throat cancer, and thyroid cancer. As a result of his fellowship training, he also specializes in minimally invasive transoral surgery, organ preserving laryngeal surgery, and microvascular free flap reconstruction. Microvascular free flap reconstruction involves moving a piece of tissue, with blood vessels included, to a different part of the body to preserve function after cancer therapy.
Dr. Lee’s research interests include assessment of head and neck cancer treatment outcomes and development of patient-reported outcome measures (PROMs) in order to optimize form and function. He has also studied new therapies for smell and taste loss, including the design and implementation of randomized controlled trials (RCTs).
He has published in several peer-reviewed journals, including JAMA Otolaryngology—Head & Neck Surgery, Head & Neck, Otolaryngology—Head and Neck Surgery, and Laryngoscope. He has presented to his peers at international, national, and regional meetings, including the annual meetings of the American Head and Neck Society (AHNS), American Rhinologic Society (ARS), and the American Academy of Otolaryngology—Head & Neck Surgery (AAO-HNS).
Dr. Lee is a member of the AHNS, AAO-HNS, and Triological Society. He has previously served as the chair of the AAO-HNS Foundation Section for Residents and Fellows-in-Training. -
Jason T. Lee, MD
Professor of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsDr. Lee is the Principal Investigator on several clinical trials examining therapeutic strategies for management of complex aortic aneurysm disease as well as aortic dissection.
Dr. Lees clinical interests include:
Endovascular repair of abdominal/thoracic aneurysms and dissections
Fenestrated and Branch Repair of the thoracic, thoracoabdominal, and abdominal aneurysms
Carotid stenting
Thoracic outlet syndrome
Vascular disorders in high-performance athletes -
Jennifer Lee
Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI am a clinical scientist (PhD epidemiology), endocrinologist, and CMO at VAPA Cooperative Studies Program Coordinating Center. My group does pattern and prediction mapping along the life-course of interventions/outcomes and how healthcare system can positively impact health longitudinally. We use novel molecular epi, 'big' data like EHRs using multiple designs/methods/technologies. These interests cut across multiple complex chronic diseases and lifespan.
https://med.stanford.edu/jleelab.html -
Jennifer Y Lee, MD
Clinical Associate Professor, Otolaryngology (Head and Neck Surgery)
Current Research and Scholarly InterestsDevelopment of treatment outcomes of Eustachian tube balloon dilation
-
Jin Hyung Lee
Associate Professor of Neurology and Neurological Sciences (Neurology Research), of Neurosurgery and of Bioengineering and, by courtesy, of Electrical Engineering
On Leave from 09/23/2024 To 12/22/2024Current Research and Scholarly InterestsIn vivo visualization and control of neural circuits
-
Jinwoo Lee, MD, PhD, FAAD
Clinical Scholar, Dermatology
Postdoctoral Scholar, DermatologyBioJinwoo Lee, M.D., Ph.D. is a board-certified dermatologist and clinical faculty in the Department of Dermatology. Dr. Lee completed his residency in dermatology at Stanford University, where he joined the Investigative Training Track to conduct basic science research in autoimmunity and inflammation. Dr. Lee’s scientific research focuses on identifying the mechanisms underlying the onset and progression of autoimmune diseases. His clinical interests include medical management of complex dermatologic conditions, autoimmune skin diseases, as well as general dermatology.
Dr. Lee is currently only seeing patients on Monday afternoons at the Stanford Medicine Outpatient Center in Redwood City. -
Jon B. Lee, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Assistant Professor, Emergency Medicine
Clinical Assistant Professor, Emergency MedicineBioDr. Lee is board-certified in both Emergency Medicine and Pain Medicine. He works clinically as an attending physician in both the Department of Emergency Medicine and the Division of Pain Medicine at Stanford University.
Dr. Lee offers employs multi-modal medication utilization, injection therapies, radiofrequency ablation, and neuromodulation, to help patients manage their pain and improve their quality of life. Dr. Lee’s academic interests include interventional pain management in acute care settings, ED utilization and management for acute and chronic painful conditions, and transitions of care between inpatient and outpatient settings. -
Jonathan Yong Lee (Jon Lee)
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Jon Lee, MD, MBA is a Health Policy (Health Economics) PhD candidate, Economics PhD minor candidate, and Political Science MA student. In addition, Jon Lee is a Clinical Assistant Professor of Psychiatry and Behavioral Sciences at the Depression Clinic of Stanford University where he founded the "Am I Good? Examining life through the lenses of Philosophical Skepticism, Moral Philosophy, and Existentialism" philosophical psychotherapy group.
Jon Lee's research focuses on the causes and consequences of, as well as solutions to, rising skepticism and distrust in sources of expert information (e.g., science, health). He has a special interest in exploring skepticism and persuasion at the intersection of health and politics, which includes studying phenomena such as the politicization of science and health, political polarization, filter bubbles/echo chambers, the emerging post-truth world, and information warfare. It also includes seeking heteorgeneity in the findings across particular demographics at high socioeconomic and health risk. He draws on theories and methods from his uniquely interdisciplinary set of educational, research, and professional experiences, including those from experimental and behavioral economics, political science, psychology, philosophy, and machine learning. He is currently using machine learning-based text analytics to explore how trust/distrust in sources of expert information is discussed on traditional and social media -- followed by the use of online randomized controlled survey experiments to test the causal effects of particular persuasion strategies on perceptions of trust/distrust, as well as other important behavioral outcomes of interest.
Jon Lee uses a clinical approach that consists of the use of both psychopharmacological and individual/group psychotherapeutic interventions to address depression, dissatisfaction, and unhappiness. Referred to by some as philosophical psychiatry, philosophical therapy, philosophical counseling, or philosophical psychology, Jon Lee's approach to psychotherapy/counseling begins with the building of one's worldview / lens from a first principles perspective by asking the fundamental questions posed by philosophers and scientists spanning philosophical / intellectual traditions across time, including:
existentialism / existential philosophy
philosophical empiricism
philosophical skepticism, absurdism, pessimism, nihilism
logical empiricism / logical positivism
moral / ethical philosophy, skepticism, relativism
rational skepticism / scientific skepticism
political liberalism
Questions include 'how do we know what we know?', 'what is the meaning of life?', 'what is the purpose of life?', 'does God exist?', 'what matters?', 'what is value?', 'what is good?', 'do we have moral obligations?', 'what are our moral obligations?', 'do we have rights?', 'what are rights?', 'do we have free will?', etc.
Jon Lee's approach draws heavily from the philosophical works of Epicurus, Baruch Spinoza, David Hume, Friedrich Nietzsche, Ludwig Wittgenstein, Arthur Schopenhauer, Albert Camus, Jean-Paul Sartre, John Rawles, etc. -
Julie Jung Hyun Lee
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioJulie Lee is a board-certified internal medicine physician and clinical informaticist at Stanford University. Dr. Lee's expertise in clinical informatics enables her to use informatics-driven approaches and clinically integrate AI models to improve patient health outcomes, alleviate physician burnout by streamlining workflows, and champion health equity at all levels. Dr. Lee focuses on clinical feasibility of AI implementation in healthcare systems and also leveraging patient data and AI models to identify/mitigate health disparities, making certain they function as instruments of equity rather than increasing gaps.
Dr. Lee has been key to several initiatives in improving operational processes within Stanford. Her efforts include: 1) advancing the governance and operations of Clinical Decision Support, 2) strategic integration of the Prescription Drug Monitoring Program into the electronic health record (EHR) to address the opioid crisis 3) human factors analysis of the usability of health information technology on physicians and patient outcomes. Additionally, she has worked on innovative solutions to improve patient-physician communications--including the creation of a dynamic EHR tool for better triage and processing by medical staff before a medical advice request reaches the doctors.
Health equity is her north star, informing Dr. Lee to dedicated engagement with historically underrepresented populations in medical research and collaborative partnerships between academia and community healthcare practitioners. Her previous role as an EpiScholar with the Los Angeles Department of Public Health involved researching the impact of language and acculturation on the Latino population's dietary habits and health behaviors, with a particular focus on diabetes. She has also worked with community health centers in east Los Angeles to bridge the translational gap between academic research and frontline healthcare workers, facilitating the transfer of cutting-edge liver disease research to those treating patients with substance abuse-related liver conditions.
Of major clinical interest is cardiovascular disease—she has published several papers including a landmark article on the impact of sex-specific risk factors for cardiovascular disease in women and transgender population. She is interested in improving precision health for Asians and NHPI. -
Sandra Soo-Jin Lee, Ph.D
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsDr. Lee is a medical anthropologist whose research focuses on the sociocultural dimensions and ethical issues of emerging technologies and their translation into clinical practice. Dr. Lee leads studies on the public understandings of research using clinical data and biological samples, concepts of race, culture and human genetic variation, and citizen science, commercialization of biotechnology and entrepreneurship.
-
Seolhyun Lee, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Lee is a nephrologist and Clinical Assistant Professor in the Nephrology Division of the Stanford Department of Medicine.
He delivers expert, compassionate kidney care personalized to each patient he serves. Dr. Lee is committed to improving both the health and quality of life of his patients.
His work scholarship has appeared in the Journal of the American Society of Nephrology, Kidney Week, and Blood Purification.
Dr. Lee has received honors and awards including the prestigious Ben J. Lipps Research Fellowship from the American Society of Nephrology. The program funds original research projects by nephrology fellows. -
Sukmook Lee
Visiting Professor, Neurosurgery
BioProfessor Sukmook Lee, Ph.D., is a distinguished leader in the field of antibody engineering and therapeutic antibody development. He currently serves as the Director of the Antibody Research Institute and Professor in the Department of Biopharmaceutical Chemistry at Kookmin University. Additionally, he holds a Visiting Professorship in the Department of Neurosurgery at Stanford University School of Medicine. His cutting-edge research is globally recognized, particularly for its focus on immunological disorders, infectious diseases, and cancer therapies.
As the head of the Innovative Antibodies Laboratory (InnoAbs), a globally leading research group, Professor Lee spearheads pioneering efforts to develop novel therapeutic antibodies. His lab’s work has made significant strides in cancer immunotherapy, COVID-19 treatment, and the creation of diagnostic antibodies for COVID-19. The InnoAbs Lab also collaborates extensively with academic and industrial partners to drive innovation in therapeutic targeting, cancer progression, and metastasis.
Professor Lee is widely recognized in the scientific community, serving on the editorial boards of high-impact journals such as Scientific Reports, Antibodies, and Frontiers in Bioscience. He also contributes as a bio-advisory board member for leading pharmaceutical companies, including Samsung Biologics, Samsung Bioepis, ISU Abxis, and Ankook Pharmaceutical. His extensive consulting work for both international and domestic industries highlights his pivotal role in bridging academic research with practical medical applications. In addition, he serves as a steering committee member for the Korean Society for Biochemistry and Molecular Biology (KSBMB) and the Antibody Society of Korea (ASK), and is an active member of The Antibody Society and the American Association for Cancer Research (AACR) in the USA.
A visionary researcher, Professor Lee continues to push the boundaries of modern medicine, particularly through his efforts to commercialize groundbreaking antibody platforms for cancer and viral therapies, bringing new hope to patients worldwide.
